Alternatives to Care Clinics

The lowest medication price on this roster, and a headline that still leaves out a required charge. Compounded semaglutide is $59 a month and tirzepatide $69, flat at every dose and cancellable at any time — both requiring a $199 annual membership the pricing line never mentions. Counted properly the first year is $907 for semaglutide, about $76 a month, and $1,027 for tirzepatide, about $86, which remains among the cheapest anywhere even after the fee. It is operated by Health For Everyone Inc., trading as CollectiveOS, and positioned on being brought to you by the founder of Thrive Market and on GLP-1s without the 500% markup. There is a 21-day free trial before the membership charge, after which the fee is non-refundable with no partial periods returned. The compounding pharmacies are never named, no state list is published, and no time to first dose is given.

From $133/mo semaglutide, $209/mo tirzepatide, all 50 states, and an explicit pregnancy/breastfeeding exclusion most competitors don't bother disclosing — the price just isn't flat, it's tiered by how many months you prepay.

A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included partner if you can live with a yearly plan and a pharmacy it doesn't name.

From $149 semaglutide, $196 tirzepatide, one bundled price, flat at every dose. Two conditions the cards do not carry: the price buys four weeks, not a month, and it requires a three-month plan — that qualifier appears only in the intake API. No month-to-month rate is reachable without an account. FDA letter 728281 from June 2026, still open, and the cited 'FDA-Approved' claim is still live on an indexable page.

From $149 semaglutide, $179 tirzepatide, one bundled price, flat at every dose, all 50 states and D.C. The price buys four weeks — stated in its own terms — and requires a three-month plan, a condition shown in the funnel but not on the homepage cards. The month-to-month tier sits behind the intake and is not published. FDA screen clean against a passing control.

It names semaglutide, tirzepatide and a microdose, and prices none of them. The only figure anywhere is a “from $149” attached to no product, so the real cost arrives after intake.

A one-product shop — compounded tirzepatide microdosing only, $89 the first month then $199/mo all-in, no live video visit described anywhere in the flow, and unusually candid on-site that the trial evidence for microdosing specifically is thin — but there's no semaglutide option at all, and no individual physician, pharmacy, or state list named anywhere on the site checked.

No published price, and no phone number or postal address behind it — the only contact is an email. It also runs the same compiled application as two other GLP-1 brands.

Compounded semaglutide at $99 a month and tirzepatide at $149, with the provider visit, two-day shipping and injection supplies all included — genuinely cheap for what is in the box. The catch is in what 'no subscription, ever' actually means here. Those rates are six-month programs, paid as one payment up front. The shortest commitment on offer is three months at $165 a month, and maintenance afterwards runs $199. There is no month-to-month option at all, so the flexibility the phrase implies is the opposite of what is on sale. It also names no company anywhere — an address in Dallas and a phone number, but no legal entity.